On June 26, 2018, the board of directors of Oncolix, Inc. voted to increase the number of directors to five from the current four, and elected Sherry Grisewood to serve as a director until her resignation or replacement by action of the stockholders of the company. Ms. Grisewood is currently the chairman of the audit committee and is a member of the compensation committee for Tapimmune, Inc.